Pfizer Reviewing Strategic Alternatives for Consumer Healthcare Business
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Buildings collapse as quake rocks north-central Venezuela, capital Caracas
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
Pfizer (PFE) Consumer Health Unit Sale Would Be 'Incrementally Positive' - BMO
October 10, 2017 10:23 AM EDTBMO Capital analyst Alex Arfaei views Pfizer (NYSE: PFE) potential sale of its Consumer Health unit as an "incremental positive."
Arfaei notes Consumer Healthcare generated $3.4B in 2016, and they estimate that it could be worth ~5-6x revenue.
"While a decision is... More
